Vanda Pharmaceuticals (VNDA)
(Delayed Data from NSDQ)
$5.36 USD
+0.23 (4.48%)
Updated May 15, 2024 04:00 PM ET
After-Market: $5.37 +0.01 (0.19%) 7:58 PM ET
3-Hold of 5 3
B Value B Growth B Momentum B VGM
Earnings News For VNDA
-
Vanda: Q1 Earnings Snapshot
-
Vanda Pharmaceuticals Reports First Quarter 2024 Financial Results
-
Vanda (VNDA) to Report Q1 Earnings: What's in the Cards?
-
Vanda: Q4 Earnings Snapshot
-
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results
-
Vanda Pharmaceuticals (VNDA) Reports Break-Even Earnings for Q3
-
Vanda Pharmaceuticals Reports Third Quarter 2023 Financial Results
-
Vanda: Q2 Earnings Snapshot
-
Vanda Pharmaceuticals Reports Second Quarter 2023 Financial Results
-
Vanda: Q1 Earnings Snapshot
-
Vanda Pharmaceuticals Reports First Quarter 2023 Financial Results
-
Vanda: Q4 Earnings Snapshot
-
Vanda Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results
-
Vanda Pharmaceuticals (VNDA) Lags Q3 Earnings and Revenue Estimates
-
Vanda: Q3 Earnings Snapshot
-
Vanda Pharmaceuticals Reports Third Quarter 2022 Financial Results
-
Vanda Pharmaceuticals (VNDA) Q2 Earnings and Revenues Miss Estimates
-
Vanda: Q2 Earnings Snapshot
-
Vanda Pharmaceuticals Reports Second Quarter 2022 Financial Results
-
Vanda Pharmaceuticals (VNDA) Reports Q1 Loss, Tops Revenue Estimates
-
Earnings Preview: Vanda Pharmaceuticals (VNDA) Q1 Earnings Expected to Decline
-
Vanda Pharmaceuticals (VNDA) Misses Q3 Earnings and Revenue Estimates
-
Vanda Pharmaceuticals (VNDA) Earnings Expected to Grow: What to Know Ahead of Q3 Release
-
Vanda Pharmaceuticals (VNDA) Matches Q2 Earnings Estimates
-
Vanda Pharmaceuticals (VNDA) Surpasses Q1 Earnings and Revenue Estimates